Karolinska Development
Trending Articles
Related Content
Finance
Karolinska Development portfolio company Promimic AB appoints Magnus Larsson as new CEO and launches US sales operation
Karolinska Development AB has announced that its portfolio company Promimic AB, an innovative biomaterials company developing and commercialising medical implant technologies that enhance bone healing, has announced the appointment of Magnus Larsson as Chief Executive Officer.
Regulatory
Karolinska Development portfolio company Dilafor AB granted U.S. patent for Phase II drug tafoxiparin
Karolinska Development AD has announced that its portfolio company Dilafor AB, a drug development company focusing on the development of tafoxiparin for obstetric indications, has been granted a U.S. patent protecting its proprietary compound tafoxiparin.